Clinical Trial Update: Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx [Phase 4]

View source ↗

Summary

Clinical trial investigating radiotherapy dose escalation in locally advanced squamous cell carcinoma of the larynx or hypopharynx has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Larynx or Hypopharynx

Snippet

Sponsor: University of Florida | Conditions: Advanced Squamous Cell Carcinoma | Phase 4 | Status: WITHDRAWN